Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
Cells|August 7, 2021
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted TherapyCarla De Giovanni, Lorena Landuzzi, Arianna Palladini, et al.Future Oncology (London, England)|March 25, 2006
Cancer immunopreventionPier-Luigi Lollini, Carla De Giovanni, Tania Pannellini, et al.Reviews in Medical Virology|June 1, 2011
Rethinking herpes simplex virus: the way to oncolytic agentsGabriella Campadelli-Fiume, Carla De Giovanni, Valentina Gatta, et al.BMC Bioinformatics|November 26, 2010
Modeling the competition between lung metastases and the immune system using agentsMarzio Pennisi, Francesco Pappalardo, Ariannna Palladini, et al.Immunology Letters|December 26, 2001
Immunological prevention of spontaneous tumors: a new prospect?Elena Quaglino, Stefania Rovero, Federica Cavallo, et al.Current Drug Targets|December 17, 2010
Vaccines and other immunological approaches for cancer immunopreventionPier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.Gastroenterology Clinics of North America|December 20, 2002
Immunoprevention of colorectal cancer: a future possibility?Pier-Luigi Lollini, Carla De Giovanni, Giordano Nicoletti, et al.Oncology Reports|July 6, 2007
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cellsStefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.Pathology Oncology Research : POR|December 26, 2007
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesisStefania Croci, Lorena Landuzzi, Giordano Nicoletti, et al.International Journal of Cancer|January 30, 2004
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosityCarla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, et al.Pageof 8